-
1
-
-
0029762813
-
Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms
-
Fink A, Tomlinson G, Freeman JL, Rosen IB, Asa SL. Occult micropapillary carcinoma associated with benign follicular thyroid disease and unrelated thyroid neoplasms. Mod. Pathol. 1996; 9; 816-820.
-
(1996)
Mod. Pathol.
, vol.9
, pp. 816-820
-
-
Fink, A.1
Tomlinson, G.2
Freeman, J.L.3
Rosen, I.B.4
Asa, S.L.5
-
2
-
-
75149121483
-
Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF (V600E) mutation, clinicopathological features, and immunohistochemical findings
-
Park YJ, Kim YA, Lee YJ et al. Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF (V600E) mutation, clinicopathological features, and immunohistochemical findings. Head Neck 2010; 32; 38-45.
-
(2010)
Head Neck
, vol.32
, pp. 38-45
-
-
Park, Y.J.1
Kim, Y.A.2
Lee, Y.J.3
-
3
-
-
33646450280
-
Managing small thyroid cancers
-
Mazzaferri EL. Managing small thyroid cancers. JAMA 2006; 295; 2.
-
(2006)
JAMA
, vol.295
, pp. 2
-
-
Mazzaferri, E.L.1
-
4
-
-
35148819235
-
Management of low-risk differentiated thyroid cancer
-
Mazzaferri EL. Management of low-risk differentiated thyroid cancer. Endocr. Pract. 2007; 13; 498-512.
-
(2007)
Endocr. Pract.
, vol.13
, pp. 498-512
-
-
Mazzaferri, E.L.1
-
5
-
-
35148882555
-
Management of patients with low-risk papillary thyroid carcinoma
-
Hay ID. Management of patients with low-risk papillary thyroid carcinoma. Endocr. Pract. 2007; 13; 521-533.
-
(2007)
Endocr. Pract.
, vol.13
, pp. 521-533
-
-
Hay, I.D.1
-
6
-
-
0036983115
-
The Ras-Raf-MEK-ERK pathway in the treatment of cancer
-
Hilger RA, Scheulen ME, Strumberg D. The Ras-Raf-MEK-ERK pathway in the treatment of cancer. Onkologie 2002; 25; 511-518.
-
(2002)
Onkologie
, vol.25
, pp. 511-518
-
-
Hilger, R.A.1
Scheulen, M.E.2
Strumberg, D.3
-
7
-
-
0041589377
-
High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines
-
Xu X, Quiros RM, Gattuso P, Ain KB, Prinz RA. High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Cancer Res. 2003; 63; 4561-4567.
-
(2003)
Cancer Res.
, vol.63
, pp. 4561-4567
-
-
Xu, X.1
Quiros, R.M.2
Gattuso, P.3
Ain, K.B.4
Prinz, R.A.5
-
8
-
-
0141453014
-
Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers
-
Namba H, Nakashima M, Hayashi T et al. Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers. J. Clin. Endocrinol. Metab. 2003; 88; 4393-4397.
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 4393-4397
-
-
Namba, H.1
Nakashima, M.2
Hayashi, T.3
-
9
-
-
2442568538
-
BRAF (V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas
-
Puxeddu E, Moretti S, Elisei R et al. BRAF (V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas. J. Clin. Endocrinol. Metab. 2004; 89; 2414-2420.
-
(2004)
J. Clin. Endocrinol. Metab.
, vol.89
, pp. 2414-2420
-
-
Puxeddu, E.1
Moretti, S.2
Elisei, R.3
-
10
-
-
21544464303
-
Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness
-
Trovisco V, Soares P, Preto A et al. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness. Virchows Arch. 2005; 446; 589-595.
-
(2005)
Virchows Arch.
, vol.446
, pp. 589-595
-
-
Trovisco, V.1
Soares, P.2
Preto, A.3
-
11
-
-
33745074644
-
Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature
-
Fugazzola L, Puxeddu E, Avenia N et al. Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature. Endocr. Relat. Cancer 2006; 13; 455-464.
-
(2006)
Endocr. Relat. Cancer
, vol.13
, pp. 455-464
-
-
Fugazzola, L.1
Puxeddu, E.2
Avenia, N.3
-
12
-
-
34548192281
-
The prevalence and prognostic value of BRAF mutation in thyroid cancer
-
Kebebew E, Weng J, Bauer J et al. The prevalence and prognostic value of BRAF mutation in thyroid cancer. Ann. Surg. 2007; 246; 466-471.
-
(2007)
Ann. Surg.
, vol.246
, pp. 466-471
-
-
Kebebew, E.1
Weng, J.2
Bauer, J.3
-
13
-
-
16644384144
-
The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma
-
Sedliarou I, Saenko V, Lantsov D et al. The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma. Int. J. Oncol. 2004; 25; 1729-1735.
-
(2004)
Int. J. Oncol.
, vol.25
, pp. 1729-1735
-
-
Sedliarou, I.1
Saenko, V.2
Lantsov, D.3
-
14
-
-
27744512441
-
The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma
-
Kim TY, Kim WB, Song JY et al. The BRAF mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma. Clin. Endocrinol. 2005; 63; 588-593.
-
(2005)
Clin. Endocrinol.
, vol.63
, pp. 588-593
-
-
Kim, T.Y.1
Kim, W.B.2
Song, J.Y.3
-
15
-
-
59449090715
-
Analysis of differential BRAF (V600E) mutational status in high aggressive papillary thyroid microcarcinoma
-
Lee X, Gao M, Ji Y et al. Analysis of differential BRAF (V600E) mutational status in high aggressive papillary thyroid microcarcinoma. Ann. Surg. Oncol. 2009; 16; 240-245.
-
(2009)
Ann. Surg. Oncol.
, vol.16
, pp. 240-245
-
-
Lee, X.1
Gao, M.2
Ji, Y.3
-
16
-
-
0031046294
-
A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins
-
Bork P, Hofmann K, Bucher P, Neuwald AF, Altschul SF, Koonin EV. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB J. 1997; 11; 68-76.
-
(1997)
FASEB J.
, vol.11
, pp. 68-76
-
-
Bork, P.1
Hofmann, K.2
Bucher, P.3
Neuwald, A.F.4
Altschul, S.F.5
Koonin, E.V.6
-
17
-
-
0036500691
-
Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure
-
Joo WS, Jeffrey PD, Cantor SB, Finnin MS, Livingston DM, Pavletich NP. Structure of the 53BP1 BRCT region bound to p53 and its comparison to the Brca1 BRCT structure. Genes Dev. 2002; 16; 583-593.
-
(2002)
Genes Dev.
, vol.16
, pp. 583-593
-
-
Joo, W.S.1
Jeffrey, P.D.2
Cantor, S.B.3
Finnin, M.S.4
Livingston, D.M.5
Pavletich, N.P.6
-
18
-
-
0038143321
-
Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX
-
Ward IM, Minn K, Jorda KG, Chen J. Accumulation of checkpoint protein 53BP1 at DNA breaks involves its binding to phosphorylated histone H2AX. J. Biol. Chem. 2003; 278; 19579-19582.
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 19579-19582
-
-
Ward, I.M.1
Minn, K.2
Jorda, K.G.3
Chen, J.4
-
19
-
-
0034739853
-
p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks
-
Schultz LB, Chehab NH, Malikzay A, Halazonetis TD. p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks. J. Cell Biol. 2000; 151; 1381-1390.
-
(2000)
J. Cell Biol.
, vol.151
, pp. 1381-1390
-
-
Schultz, L.B.1
Chehab, N.H.2
Malikzay, A.3
Halazonetis, T.D.4
-
20
-
-
0035972194
-
Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways
-
Rappold I, Iwabuchi K, Date T, Chen J. Tumor suppressor p53 binding protein 1 (53BP1) is involved in DNA damage-signaling pathways. J. Cell Biol. 2001; 153; 613-620.
-
(2001)
J. Cell Biol.
, vol.153
, pp. 613-620
-
-
Rappold, I.1
Iwabuchi, K.2
Date, T.3
Chen, J.4
-
21
-
-
0035134286
-
Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage
-
Anderson L, Henderson C, Adachi Y. Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage. Mol. Cell. Biol. 2001; 21; 1719-1729.
-
(2001)
Mol. Cell. Biol.
, vol.21
, pp. 1719-1729
-
-
Anderson, L.1
Henderson, C.2
Adachi, Y.3
-
22
-
-
0035951850
-
Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1
-
Xia Z, Morales JC, Dunphy WG, Carpenter PB. Negative cell cycle regulation and DNA damage-inducible phosphorylation of the BRCT protein 53BP1. J. Biol. Chem. 2001; 276; 2708-2718.
-
(2001)
J. Biol. Chem.
, vol.276
, pp. 2708-2718
-
-
Xia, Z.1
Morales, J.C.2
Dunphy, W.G.3
Carpenter, P.B.4
-
23
-
-
0034798285
-
ATM: genome stability, neuronal development, and cancer cross paths
-
Shiloh Y, Kastan MB. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 2001; 83; 209-254.
-
(2001)
Adv. Cancer Res.
, vol.83
, pp. 209-254
-
-
Shiloh, Y.1
Kastan, M.B.2
-
24
-
-
0029821651
-
Dual roles of ATM in the cellular response to radiation and in cell growth control
-
Xu Y, Baltimore D. Dual roles of ATM in the cellular response to radiation and in cell growth control. Genes Dev. 1996; 10; 2401-2410.
-
(1996)
Genes Dev.
, vol.10
, pp. 2401-2410
-
-
Xu, Y.1
Baltimore, D.2
-
25
-
-
0031806910
-
Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice
-
Xu Y, Yang EM, Brugarolas J, Jacks T, Baltimore D. Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice. Mol. Cell. Biol. 1998; 18; 4385-4390.
-
(1998)
Mol. Cell. Biol.
, vol.18
, pp. 4385-4390
-
-
Xu, Y.1
Yang, E.M.2
Brugarolas, J.3
Jacks, T.4
Baltimore, D.5
-
26
-
-
0346059615
-
53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage
-
Mochan TA, Venere M, DiTullio RA Jr, Halazonetis TD. 53BP1 and NFBD1/MDC1-Nbs1 function in parallel interacting pathways activating ataxia-telangiectasia mutated (ATM) in response to DNA damage. Cancer Res. 2003; 63; 8586-8591.
-
(2003)
Cancer Res.
, vol.63
, pp. 8586-8591
-
-
Mochan, T.A.1
Venere, M.2
DiTullio Jr., R.A.3
Halazonetis, T.D.4
-
27
-
-
33845936217
-
Quantitative analysis of radiation-induced DNA break repair in a cultured oral mucosal model
-
Rakhorst HA, Tra WM, Posthumus-Van Sluijs ST et al. Quantitative analysis of radiation-induced DNA break repair in a cultured oral mucosal model. Tissue Eng. 2006; 12; 3395-3403.
-
(2006)
Tissue Eng.
, vol.12
, pp. 3395-3403
-
-
Rakhorst, H.A.1
Tra, W.M.2
Posthumus-Van Sluijs, S.T.3
-
28
-
-
38749090568
-
Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis
-
Nakashima M, Suzuki K, Meirmanov S et al. Foci formation of P53-binding protein 1 in thyroid tumors: activation of genomic instability during thyroid carcinogenesis. Int. J. Cancer 2008; 122; 1082-1088.
-
(2008)
Int. J. Cancer
, vol.122
, pp. 1082-1088
-
-
Nakashima, M.1
Suzuki, K.2
Meirmanov, S.3
-
29
-
-
43649095626
-
Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability
-
Naruke Y, Nakashima M, Suzuki K et al. Alteration of p53-binding protein 1 expression during skin carcinogenesis: association with genomic instability. Cancer Sci. 2008; 99; 946-951.
-
(2008)
Cancer Sci.
, vol.99
, pp. 946-951
-
-
Naruke, Y.1
Nakashima, M.2
Suzuki, K.3
-
30
-
-
80053298313
-
Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: endogenous DNA double strand breaks and genomic instability during carcinogenesis
-
Matsuda K, Miura S, Kurashige T et al. Significance of p53-binding protein 1 nuclear foci in uterine cervical lesions: endogenous DNA double strand breaks and genomic instability during carcinogenesis. Histopathology 2011; 59; 441-451.
-
(2011)
Histopathology
, vol.59
, pp. 441-451
-
-
Matsuda, K.1
Miura, S.2
Kurashige, T.3
-
31
-
-
0037373853
-
Delayed reactivation of p53 in the progeny of cells surviving ionizing radiation
-
Suzuki K, Yokoyama S, Waseda S, Kodama S, Watanabe M. Delayed reactivation of p53 in the progeny of cells surviving ionizing radiation. Cancer Res. 2003; 63; 936-941.
-
(2003)
Cancer Res.
, vol.63
, pp. 936-941
-
-
Suzuki, K.1
Yokoyama, S.2
Waseda, S.3
Kodama, S.4
Watanabe, M.5
-
32
-
-
68549087243
-
Genomic instability in the epidermis induced by atomic bomb (A-bomb) radiation: a long-lasting health effect in A-bomb survivors
-
Naruke Y, Nakashima M, Suzuki K et al. Genomic instability in the epidermis induced by atomic bomb (A-bomb) radiation: a long-lasting health effect in A-bomb survivors. Cancer 2009; 115; 3782-3790.
-
(2009)
Cancer
, vol.115
, pp. 3782-3790
-
-
Naruke, Y.1
Nakashima, M.2
Suzuki, K.3
-
33
-
-
16844367605
-
Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells
-
Mitsutake N, Knauf JA, Mitsutake S, Mesa C Jr, Zhang L, Fagin JA. Conditional BRAFV600E expression induces DNA synthesis, apoptosis, dedifferentiation, and chromosomal instability in thyroid PCCL3 cells. Cancer Res. 2005; 65; 2465-2473.
-
(2005)
Cancer Res.
, vol.65
, pp. 2465-2473
-
-
Mitsutake, N.1
Knauf, J.A.2
Mitsutake, S.3
Mesa Jr., C.4
Zhang, L.5
Fagin, J.A.6
-
34
-
-
62549101651
-
BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients
-
Ito Y, Yoshida H, Maruo R et al. BRAF mutation in papillary thyroid carcinoma in a Japanese population: its lack of correlation with high-risk clinicopathological features and disease-free survival of patients. Endocr. J. 2009; 56; 89-97.
-
(2009)
Endocr. J.
, vol.56
, pp. 89-97
-
-
Ito, Y.1
Yoshida, H.2
Maruo, R.3
-
35
-
-
82755162455
-
Significance of genomic instability in breast cancer in atomic bomb survivors: analysis of microarray-comparative genomic hybridization
-
Oikawa M, Yoshiura K, Kondo H, Miura S, Nagayasu T, Nakashima M. Significance of genomic instability in breast cancer in atomic bomb survivors: analysis of microarray-comparative genomic hybridization. Radiat. Oncol. 2011; 6; 168.
-
(2011)
Radiat. Oncol.
, vol.6
, pp. 168
-
-
Oikawa, M.1
Yoshiura, K.2
Kondo, H.3
Miura, S.4
Nagayasu, T.5
Nakashima, M.6
|